| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |